Exelixis
EXEL
264 hedge funds and large institutions have $5.88B invested in Exelixis in 2017 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 91 increasing their positions, 82 reducing their positions, and 38 closing their positions.
45% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 38
16% more call options, than puts
Call options by funds: $77.4M | Put options by funds: $66.7M
11% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 82
6% more funds holding
Funds holding: 249 → 264 (+15)
2.13% more ownership
Funds ownership: 80.46% → 82.58% (+2.1%)
2% more capital invested
Capital invested by funds: $5.79B → $5.88B (+$89.5M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$191M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$122M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$43.9M |
| 4 |
Renaissance Technologies
New York
|
+$36.2M |
| 5 |
BlackRock
New York
|
+$34.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Meditor Group
Hamilton,
Bermuda
|
-$74.9M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$55.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$47.3M |
| 4 |
Two Sigma Investments
New York
|
-$42.4M |
| 5 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$27M |
EXEL Hedge Fund Activity: Q3 2017 in Review
264 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q3 2017, worth a combined $5.88B — up 1.5% from $5.79B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new EXEL positions and 38 closed out — a net gain of 17 holders — while 91 added to existing stakes and 82 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $191M. The largest seller was Meditor Group, cutting an estimated $74.9M.
- 264 institutional investors held Exelixis (EXEL) as of Q3 2017, up from 249 in Q2 2017.
- Funds reported $5.88B of Exelixis stock for Q3 2017, up 1.5% quarter-over-quarter.
- 55 funds opened new Exelixis positions in Q3 2017 and 38 closed out, a net change of +17 holders.
- The largest Exelixis buyer in Q3 2017 was Goldman Sachs, an estimated $191M added.
- The largest Exelixis seller in Q3 2017 was Meditor Group, an estimated $74.9M sold.
Based on aggregated 13F filings for Q3 2017.